Try our beta test site
152 studies found for:    Sjögren's Syndrome
Show Display Options
Rank Status Study
21 Recruiting The ASSESS National Multi-center Prospective Cohort
Condition: Primary Sjögren's Syndrome
Intervention: Other: No intervention
22 Terminated
Has Results
Pilot Study of Raptiva to Treat Sjogren's Syndrome
Condition: Sjogren's Syndrome
Intervention: Drug: Raptiva
23 Withdrawn Abatacept for Patients With Inflammatory Arthritis Associated With Sjögren's Syndrome: an Open-Label Phase II Study
Conditions: Primary Sjogren's Syndrome;   Secondary Sjogren's Syndrome;   Inflammatory Arthritis;   Rheumatoid Arthritis
Intervention: Drug: Abatacept
24 Recruiting Early Detection of Pulmonary- and Pulmonary Vascular Disease in Sjögren Syndrome
Conditions: Sjögren Syndrome;   Pulmonary Hypertension
Intervention:
25 Not yet recruiting Acupuncture for Primary Sjögren Syndrome
Condition: Sjogren's Syndrome
Interventions: Device: acupuncture group;   Device: Sham Acupuncture group
26 Recruiting Endoscopic Treatment of Salivary Glands Affected by Sjögren's Syndrome
Condition: Sjögren's Syndrome
Interventions: Procedure: Sialoendoscopy;   Drug: saline;   Drug: hydrocortisone
27 Unknown  the Effect of HCG Treatment as a Cardiovascular Disease Morbidity Factor in Sjogren Syndrome Patients
Condition: Primary Sjogren Syndrome With Multisystem Involvement
Intervention: Other: Retrospective study
28 Recruiting Is Sjögren's Syndrome Associated With Meibomian Gland Dysfunction ?
Conditions: Sjögren's Syndrome;   Meibomian Gland Dysfunction
Interventions: Drug: Tears Naturale Forte;   Drug: liposic
29 Unknown  Confocal Microscopy and Lacrimal Gland in Sjogren's Syndrome
Condition: Primary Sjogren's Syndrome
Intervention:
30 Completed A Randomized, Parallel-Group Comparison Study of Topical Corticosteroids in Dry Eye Patients With Sjögren Syndrome
Conditions: Dry Eye Syndromes;   Sjögren Syndrome
Intervention:
31 Unknown  Sex Steroids in Sjögren's Syndrome: Effect of Substitution Treatment on Fatigue
Condition: Sjogren's Syndrome
Intervention: Drug: dehydroepiandrosterone
32 Recruiting Safety and Efficacy Study of Subcutaneous Belimumab and Intravenous Rituximab Co-administration in Subjects With Primary Sjogren's Syndrome
Condition: Sjogren's Syndrome
Interventions: Drug: Belimumab;   Drug: Rituximab;   Drug: Placebo belimumab;   Drug: Placebo rituximab
33 Terminated
Has Results
Baminercept, a Lymphotoxin-Beta Receptor Fusion Protein, for Treatment of Sjögren's Syndrome
Condition: Primary Sjögren's Syndrome
Interventions: Biological: Baminercept;   Other: Placebo
34 Recruiting Efficacy and Safety of Abatacept in Patients With Primary Sjögren's Syndrome
Condition: Sjögren's Syndrome
Intervention: Drug: Abatacept SC
35 Completed Hydroxychloroquine Versus Placebo in Primary Sjögren's Syndrome
Condition: Primary Sjögren's Syndrome
Interventions: Drug: Hydroxychloroquine;   Drug: Placebo
36 Active, not recruiting Salivary Biomarkers for Sjögren's Syndrome Detection
Condition: Sjögren's Syndrome
Intervention:
37 Completed The Functioning of Immune and Hormonal Systems in Patients With Sjogren's Syndrome and in Healthy Volunteers
Condition: Sjogren's Syndrome
Intervention:
38 Completed Evaluation of Therapeutic Effect of Bandage Contact Lenses ( BCL) on Dry Eye Caused by Sjogren's Syndrome
Condition: Sjögren's Syndrome Patients With Severe Dry Eye
Interventions: Drug: 0.02% Fm, SH;   Drug: 0.02% Fm, SH, 0.05% CsA;   Other: 0.02% Fm, SH, tBCL;   Drug: 0.02% Fm, SH, AS
39 Withdrawn Study of Pharmacodynamic Effects of VAY736 in Patients With Primary Sjögren's Syndrome
Condition: Primary Sjögren's Syndrome
Interventions: Drug: VAY736 lower dose;   Drug: VAY736 higher dose
40 Recruiting A Study of LY3090106 in Participants With Sjögren's Syndrome (SS)
Condition: Sjögren's Syndrome
Interventions: Drug: LY3090106;   Drug: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.